197 related articles for article (PubMed ID: 30235721)
21. Comparison of peripherally inserted central catheters (PICCs) versus totally implantable venous-access ports in pediatric oncology patients, a single center study.
Zhang H; Li Y; Zhu N; Li Y; Fu J; Liu J
Sci Rep; 2022 Mar; 12(1):3510. PubMed ID: 35241771
[TBL] [Abstract][Full Text] [Related]
22. Long-term clinical outcomes of the single-incision technique for implantation of implantable venous access ports via the axillary vein.
Seo TS; Song MG; Kim JS; Choi CW; Seo JH; Oh SC; Kang EJ; Lee JK; Lee SY
J Vasc Access; 2017 Jul; 18(4):345-351. PubMed ID: 28665466
[TBL] [Abstract][Full Text] [Related]
23. Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports.
Hsu CC; Kwan GN; Evans-Barns H; Rophael JA; van Driel ML
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008942. PubMed ID: 27544827
[TBL] [Abstract][Full Text] [Related]
24. Peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days.
Kang J; Chen W; Sun W; Ge R; Li H; Ma E; Su Q; Cheng F; Hong J; Zhang Y; Lei C; Wang X; Jin A; Liu W
J Vasc Access; 2017 Mar; 18(2):153-157. PubMed ID: 28218366
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of ultrasound-guided totally implantable venous access ports via the right innominate vein in adult patients with cancer: Single-centre experience and protocol.
Sun X; Xu J; Xia R; Wang C; Yu Z; Zhang J; Bai X; Jin Y
Eur J Surg Oncol; 2019 Feb; 45(2):275-278. PubMed ID: 30087070
[TBL] [Abstract][Full Text] [Related]
26. Analysis of related complications of totally implantable venous access ports in children's chemotherapy: Single center experience.
Zhang S; Xiao Z; Yang F
Medicine (Baltimore); 2022 Jul; 101(27):e29899. PubMed ID: 35801731
[TBL] [Abstract][Full Text] [Related]
27. The risk of bloodstream infection associated with totally implantable venous access ports in cancer patient: a systematic review and meta-analysis.
Jiang M; Li CL; Pan CQ; Yu L
Support Care Cancer; 2020 Jan; 28(1):361-372. PubMed ID: 31044308
[TBL] [Abstract][Full Text] [Related]
28. Outcome of totally implantable venous-access port-related infections.
Vidal M; Genillon JP; Forestier E; Trouiller S; Pereira B; Mrozek N; Aumeran C; Lesens O
Med Mal Infect; 2016 Feb; 46(1):32-8. PubMed ID: 26778362
[TBL] [Abstract][Full Text] [Related]
29. Outcome analysis in 270 radiologically guided implantations of totally implantable venous access ports via basilic vein.
Kao CY; Fu CH; Cheng YC; Chen JL; Cheng YC; Chen CC; Chai JW
J Chin Med Assoc; 2020 Mar; 83(3):295-301. PubMed ID: 31990818
[TBL] [Abstract][Full Text] [Related]
30. Mechanical recanalization for clot occlusion of venous access ports: experimental study using ports with clot occlusion.
Song MG; Seo TS; Kim BH; Kim JH
J Vasc Access; 2017 Mar; 18(2):158-162. PubMed ID: 28218362
[TBL] [Abstract][Full Text] [Related]
31. [Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port].
Crisinel M; Mahy S; Ortega-Debalon P; Buisson M; Favre JP; Chavanet P; Piroth L
Med Mal Infect; 2009 Apr; 39(4):252-8. PubMed ID: 19108966
[TBL] [Abstract][Full Text] [Related]
32. Safety of immediate use of totally implantable venous access ports in adult patients with cancer: a retrospective single-center study.
Lee J; Hur SM; Kim Z; Lim CW
Korean J Clin Oncol; 2021 Dec; 17(2):104-110. PubMed ID: 36945672
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and prognostic significance of infection of totally implantable vascular access port in solid tumor patients: A prospective cohort study.
Bailleul A; Fulgencio JP; Vimont S; Mordelet C; Ray B; Lassel L; Lapidus N; Quesnel C; Garnier M
Infect Dis Now; 2023 Oct; 53(8):104766. PubMed ID: 37543258
[TBL] [Abstract][Full Text] [Related]
34. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
[TBL] [Abstract][Full Text] [Related]
35. Health Education and Nursing Needs of Breast Cancer Patients With Totally Implantable Venous Access Ports at Different Stages.
Xie Y; Liu L; Jiao J; Li S; Wang W; Wang J; Li H
Altern Ther Health Med; 2023 Mar; 29(2):22-28. PubMed ID: 36239566
[TBL] [Abstract][Full Text] [Related]
36. Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.
Berardi R; Rinaldi S; Santini D; Vincenzi B; Giampieri R; Maccaroni E; Marcucci F; Francoletti M; Onofri A; Lucarelli A; Pierantoni C; Tonini G; Cascinu S
Support Care Cancer; 2015 May; 23(5):1295-302. PubMed ID: 25326782
[TBL] [Abstract][Full Text] [Related]
37. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
[TBL] [Abstract][Full Text] [Related]
38. Management of infections related to totally implantable venous-access ports: challenges and perspectives.
Lebeaux D; Fernández-Hidalgo N; Chauhan A; Lee S; Ghigo JM; Almirante B; Beloin C
Lancet Infect Dis; 2014 Feb; 14(2):146-59. PubMed ID: 24314751
[TBL] [Abstract][Full Text] [Related]
39. Systemic thrombolysis and anticoagulation therapy for catheter-related right atrial thrombosis caused by TIVAP: A case report and review of the literature.
Zhang Y; Shi J; Li JJ; Zhang L; Li Y
J Vasc Access; 2022 Mar; 23(2):313-317. PubMed ID: 33506722
[TBL] [Abstract][Full Text] [Related]
40. Identification of risk factors for catheter-related thrombosis in patients with totally implantable venous access ports in the forearm.
Goltz JP; Schmid JS; Ritter CO; Knödler P; Petritsch B; Kirchner J; Hahn D; Kickuth R
J Vasc Access; 2012; 13(1):79-85. PubMed ID: 21786241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
